Rough Road Ahead for Stocks? And an Under-the-Radar Winner in the Weight Loss Boom 9/25/23

<p>The yield on 10-year treasurys crossed the 4.5% mark for the first time since October 2007, but it's the benchmark’s relationship with the 2 year that caught the attention of one of our traders. Why the steeply steepening yield curve could be setting up equities for a problem period. Plus manufacturing giant Jacobs Solutions counts Eli Lilly and Novo Nordisk as two of its biggest customers. How the company is benefiting from the surging demand for weight-loss drugs.</p><p> </p><p><a href="https://www.cnbc.com/fast-money-disclaimer/"><strong>Fast Money Disclaimer</strong></a></p>